Ravandi F et al, 2020
« Back to Glossary Index« Back to Glossary Index
Ravandi F, Wei A, Dohner H, et al. CC-486 is safe and well-tolerated as maintenance therapy in elderly patients (≥75 years) with acute myeloid leukemia (AML) in first remission following induction chemotherapy: results from the phase III QUAZAR AML-001 trial. J Clin Oncol 2020;38(suppl 15):7530. https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.7530